#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2089546	B	Displacement of [3H]dexamethasone from human glucocorticoid receptor expressed in baculovirus infected Sf9 cells after overnight incubation by scintillation counting	Homo sapiens	20		cell-based format	Scientific Literature
2.	ALA2089547	F	Antagonist activity at human glucocorticoid receptor expressed in GRAF cells assessed as inhibition of dexamethasone-induced alkaline phosphatase expression after 48 hrs by reporter gene assay	Homo sapiens	20		cell-based format	Scientific Literature
3.	ALA2089548	F	Antagonist activity at glucocorticoid receptor in rat hepatocytes assessed as inhibition of dexamethasone-induced trypsine aminotransferase expression incubated for 30 mins prior to dexamethasone-induction measured after 4 hrs by reporter gene assay	Rattus norvegicus	20		cell-based format	Scientific Literature
4.	ALA2089549	B	Selectivity ratio of IC50 for human progesterone receptor to IC50 for human glucocorticoid receptor	Homo sapiens	1		assay format	Scientific Literature
5.	ALA2089550	B	Selectivity ratio of IC50 for human mineralocorticoid receptor to IC50 for human glucocorticoid receptor	Homo sapiens	1		assay format	Scientific Literature
6.	ALA2089551	B	Selectivity ratio of IC50 for human androgen receptor to IC50 for human glucocorticoid receptor	Homo sapiens	1		assay format	Scientific Literature
7.	ALA2089552	B	Selectivity ratio of IC50 for human ERalpha/beta to IC50 for human glucocorticoid receptor	Homo sapiens	1		assay format	Scientific Literature
8.	ALA2089553	B	Selectivity ratio of IC50 for human TRalpha/beta to IC50 for human glucocorticoid receptor	Homo sapiens	1		assay format	Scientific Literature
9.	ALA2089554	F	Passive antagonist activity at glucocorticoid receptor expressed in human HuH7 cells coexpressing VP16 assessed up to 100 uM by luciferase reporter gene assay		1		cell-based format	Scientific Literature
10.	ALA2089555	A	Tmax in Sprague-Dawley rat at 20 mg/kg, po administered as single dose	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA2089556	A	Cmax in Sprague-Dawley rat at 20 mg/kg, po administered as single dose	Rattus norvegicus	1		organism-based format	Scientific Literature
12.	ALA2089557	A	Half life in Sprague-Dawley rat at 20 mg/kg, po administered as single dose	Rattus norvegicus	1		organism-based format	Scientific Literature
13.	ALA2089558	A	AUC (0 to infinity) in Sprague-Dawley rat at 20 mg/kg, po administered as single dose	Rattus norvegicus	1		organism-based format	Scientific Literature
14.	ALA2089559	A	AUC in Sprague-Dawley rat at 20 mg/kg, iv administered as single dose	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA2089560	A	Oral bioavailability in Sprague-Dawley rat	Rattus norvegicus	1		organism-based format	Scientific Literature
16.	ALA2089561	A	Drug uptake in Sprague-Dawley rat liver at 20 mg/kg, po administered as single dose measured at 0.5 hrs	Rattus norvegicus	1		organism-based format	Scientific Literature
17.	ALA2089562	A	Ratio of drug uptake in liver to plasma in Sprague-Dawley rat at 20 mg/kg, po administered as single dose	Rattus norvegicus	1		organism-based format	Scientific Literature
18.	ALA2089658	F	Antidiabetic activity in po dosed ob/ob mouse assessed as decrease in post-prandial blood glucose level administered BID for 28 days measured 16 hrs post-last dose	Mus musculus	1		organism-based format	Scientific Literature
19.	ALA2089659	F	Antidiabetic activity in ob/ob mouse assessed as decrease in post-prandial blood glucose level at 10 mg/kg, po administered BID for 28 days measured 16 hrs post-last dose relative to vehicle-treated control	Mus musculus	1		organism-based format	Scientific Literature
20.	ALA2089660	F	Antidiabetic activity in ob/ob mouse assessed as decrease in post-prandial blood glucose level at 20 mg/kg, po administered BID for 28 days measured 16 hrs post-last dose relative to vehicle-treated control	Mus musculus	1		organism-based format	Scientific Literature